Product References
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma.
Frontiers in cell and developmental biology
Battaglia AM,Sacco A,Aversa I,Santamaria G,Palmieri C,Botta C,De Stefano R,Bitetto M,Petriaggi L,Giorgio E,Faniello CM,Costanzo F,Biamonte F
PA5-28115 was used in Western Blotting to demonstrate that iron abundance within the TME may enhance PD-L1 expression in LUAD and, thus, open the way for the identification of possible combinatorial strategies that take into account the iron levels within the TME to improve the outcomes of LUAD patients treated with anti-PD-1/PD-L1-based therapies.
Sat Jul 01 00:00:00 EDT 2023
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma.
Frontiers in cell and developmental biology
Battaglia AM,Sacco A,Aversa I,Santamaria G,Palmieri C,Botta C,De Stefano R,Bitetto M,Petriaggi L,Giorgio E,Faniello CM,Costanzo F,Biamonte F
PA5-28115 was used in Western Blotting to demonstrate that iron abundance within the TME may enhance PD-L1 expression in LUAD and, thus, open the way for the identification of possible combinatorial strategies that take into account the iron levels within the TME to improve the outcomes of LUAD patients treated with anti-PD-1/PD-L1-based therapies.
Sat Jul 01 00:00:00 EDT 2023
Immunohistochemical Profiling of PD-1, PD-L1, CD8, MSI, and p53 and Prognostic Implications in Advanced Serous Ovarian Carcinoma: A Retrospective Study.
Journal of personalized medicine
Dergham AP,Vaz de Paula CB,Nagashima S,Olandoski M,de Noronha L,Sotomaior VS
PA5-28115 was used in Immunohistochemistry to evaluate the expression of PD-1, PD-L1, CD8, MSI (MLH1, MSH2, MSH6, and PMS2), and p53 in the paraffin samples of high-grade serous ovarian carcinoma.
Mon Jun 26 00:00:00 EDT 2023
Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor.
NPJ breast cancer
Ng DYX,Li Z,Lee E,Kok JST,Lee JY,Koh J,Ng CC,Lim AH,Liu W,Ng SR,Lim KS,Huang XX,Hong JH,Guan P,Sim Y,Thike AA,Nasir NDM,Li S,Tan PH,Teh BT,Chan JY
Published figure using PD-L1 polyclonal antibody (Product # PA5-28115) in Western Blot
Fri Apr 01 00:00:00 EDT 2022
Evaluation PD-L1, CD8 and CD20 as early predictor and tracking markers for breast cancer (BC) in Egypt.
Heliyon
Hamed MM,Gouida MS,Abd El-Aziz SR,El-Sokkary AMA
PA5-28115 was used in Immunohistochemistry to conclude that PD-L1, CD8, and CD20 are considered as early predictor and tracking markers for breast cancer.
Sun May 01 00:00:00 EDT 2022
Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration.
Cancer cell international
Zhu J,Huang R,Yang R,Xiao Y,Yan J,Zheng C,Xiao W,Huang C,Wang Y
Published figure using PD-L1 polyclonal antibody (Product # PA5-28115) in Western Blot
Tue Oct 12 00:00:00 EDT 2021
Deep Phenotypic Characterisation of CTCs by Combination of Microfluidic Isolation (IsoFlux) and Imaging Flow Cytometry (ImageStream).
Cancers
Ruiz-Rodríguez AJ,Molina-Vallejo MP,Aznar-Peralta I,González Puga C,Cañas García I,González E,Lorente JA,Serrano MJ,Garrido-Navas MC
PA5-28115 was used in Flow cytometry/Cell sorting to develop a novel protocol combining two platforms (IsoFluxTM and ImageStream®X) to improve circulating tumour cells evaluation.
Mon Dec 20 00:00:00 EST 2021
MLLT6 maintains PD-L1 expression and mediates tumor immune resistance.
EMBO reports
Sreevalsan S,Döring M,Paszkowski-Rogacz M,Brux M,Blanck C,Meyer M,Momburg F,Buchholz F,Theis M
PA5-28115 was used in Western Blotting to establish MLLT6 as a regulator of oncogenic and interferon-γ-associated immune resistance.
Thu Dec 03 00:00:00 EST 2020
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
Cell communication and signaling : CCS
Wang Y,Sun Q,Mu N,Sun X,Wang Y,Fan S,Su L,Liu X
PA5-28115 was used in Western Blotting to investigate the function of USP22 upon PD-L1 in human cancer cells.
Tue Jul 14 00:00:00 EDT 2020
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells.
Cell communication and signaling : CCS
Wang Y,Sun Q,Mu N,Sun X,Wang Y,Fan S,Su L,Liu X
PA5-28115 was used in Western Blotting to investigate the function of USP22 upon PD-L1 in human cancer cells.
Tue Jul 14 00:00:00 EDT 2020
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer.
medRxiv : the preprint server for health sciences
Lovly CM,Boyd KL,Gonzalez-Ericsson PI,Lowe CL,Brown HM,Hoffman RD,Sterling BC,Kapp ME,Johnson DB,Kopparapu PR,Iams WT,Warren MA,Noto MJ,Rini BI,Jagasia M,Das SR,Balko JM
PA5-28115 was used in Immunohistochemistry to report a case of acute lung injury in a lung cancer patient initially treated for ICI-pneumonitis and later found to have concurrent SARS-CoV-2 infection.
Fri May 01 00:00:00 EDT 2020
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer.
medRxiv : the preprint server for health sciences
Lovly CM,Boyd KL,Gonzalez-Ericsson PI,Lowe CL,Brown HM,Hoffman RD,Sterling BC,Kapp ME,Johnson DB,Kopparapu PR,Iams WT,Warren MA,Noto MJ,Rini BI,Jagasia M,Das SR,Balko JM
PA5-28115 was used in Immunohistochemistry to report a case of acute lung injury in a lung cancer patient initially treated for ICI-pneumonitis and later found to have concurrent SARS-CoV-2 infection.
Fri May 01 00:00:00 EDT 2020
A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis.
Nature medicine
Johnson DB,McDonnell WJ,Gonzalez-Ericsson PI,Al-Rohil RN,Mobley BC,Salem JE,Wang DY,Sanchez V,Wang Y,Chastain CA,Barker K,Liang Y,Warren S,Beechem JM,Menzies AM,Tio M,Long GV,Cohen JV,Guidon AC,O'Hare M,Chandra S,Chowdhary A,Lebrun-Vignes B,Goldinger SM,Rushing EJ,Buchbinder EI,Mallal SA,Shi C,Xu Y,Moslehi JJ,Sanders ME,Sosman JA,Balko JM
PA5-28115 was used in Immunohistochemistry to identify if CD4+ and CD8+ T cells are potential culprits of checkpoint inhibitor-associated immune encephalitis.
Thu Aug 01 00:00:00 EDT 2019
HDAC6‑selective inhibitor synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma.
International journal of oncology
Won HR,Lee DH,Yeon SK,Ryu HW,Kim GW,Kwon SH
PA5-28115 was used in Western Blotting to investigate the interaction between the HDAC6 inhibitor, A452, and immunomodulatory drugs on dexamethasone-sensitive and -resistant multiple myeloma cells compared with the current clinically tested HDAC6 inhibitor, ACY-1215.
Thu Aug 01 00:00:00 EDT 2019
Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.
Molecular imaging
Jagoda EM,Vasalatiy O,Basuli F,Opina ACL,Williams MR,Wong K,Lane KC,Adler S,Ton AT,Szajek LP,Xu B,Butcher D,Edmondson EF,Swenson RE,Greiner J,Gulley J,Eary J,Choyke PL
Published figure using PD-L1 polyclonal antibody (Product # PA5-28115) in Immunohistochemistry
Tue Aug 27 00:00:00 EDT 2019
The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells.
International journal of oncology
Lee DH,Won HR,Ryu HW,Han JM,Kwon SH
PA5-28115 was used in Western Blotting to suggest that a therapeutic strategy that combines ACY-1215 and oxaliplatin warrants attention for the treatment of solid tumors, including CRC.
Wed Aug 01 00:00:00 EDT 2018
Cancer immunotherapy using PolyPurine Reverse Hoogsteen hairpins targeting the PD-1/PD-L1 pathway in human tumor cells.
PloS one
Medina Enríquez MM,Félix AJ,Ciudad CJ,Noé V
Published figure using PD-L1 polyclonal antibody (Product # PA5-28115) in Western Blot
Wed Apr 17 00:00:00 EDT 2019
A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression.
Frontiers in immunology
García-Hernández ML,Uribe-Uribe NO,Espinosa-González R,Kast WM,Khader SA,Rangel-Moreno J
Published figure using PD-L1 polyclonal antibody (Product # PA5-28115) in Immunofluorescence
Wed Nov 20 00:00:00 EST 2019
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
Molecular oncology
M L,P PV,T K,M P,E S,J P,K V W,C L,F C,S D,M SKS,M M,A K,J PI,A S,E S,J W,E M S,A V
PA5-28115 was used in western blot to characterize regulation of PD-L1 in melanoma by HDAC6
Sun May 01 00:00:00 EDT 2016
Essential role of HDAC6 in the regulation of PD-L1 in melanoma.
Molecular oncology
M L,P PV,T K,M P,E S,J P,K V W,C L,F C,S D,M SKS,M M,A K,J PI,A S,E S,J W,E M S,A V
PA5-28115 was used in western blot to characterize regulation of PD-L1 in melanoma by HDAC6
Sun May 01 00:00:00 EDT 2016